Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Chemours (CC) Equity Income (2016 - 2025)

Chemours has reported Equity Income over the past 12 years, most recently at $8.0 million for Q4 2025.

  • Quarterly results put Equity Income at $8.0 million for Q4 2025, down 11.11% from a year ago — trailing twelve months through Dec 2025 was $34.0 million (down 22.73% YoY), and the annual figure for FY2025 was $35.0 million, down 18.6%.
  • Equity Income for Q4 2025 was $8.0 million at Chemours, down from $9.0 million in the prior quarter.
  • Over the last five years, Equity Income for CC hit a ceiling of $16.0 million in Q2 2022 and a floor of $7.0 million in Q4 2023.
  • Median Equity Income over the past 5 years was $11.0 million (2021), compared with a mean of $11.0 million.
  • Biggest five-year swings in Equity Income: skyrocketed 200.0% in 2021 and later crashed 38.46% in 2025.
  • Chemours' Equity Income stood at $11.0 million in 2021, then changed by 0.0% to $11.0 million in 2022, then tumbled by 36.36% to $7.0 million in 2023, then rose by 28.57% to $9.0 million in 2024, then fell by 11.11% to $8.0 million in 2025.
  • The last three reported values for Equity Income were $8.0 million (Q4 2025), $9.0 million (Q3 2025), and $9.0 million (Q2 2025) per Business Quant data.